A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

检 索： 期刊全称 刊名关键词 ISSN         高级检索

期刊名称：AMERICAN JOURNAL OF PSYCHIATRY ISSN： 0002-953X 出版频率： Monthly 出版社： AMER PSYCHIATRIC PUBLISHING, INC, 800 MAINE AVE SW, SUITE 900, WASHINGTON, USA, DC, 20024 期刊网址： http://ajp.psychiatryonline.org/ 影响因子： 18.112 (2020年) 13.655(2018年) 13.396(2017年) 14.176(2016年) 13.505(2015年) 12.295(2014年) 13.559(2013年) 14.721 (2012年) 12.539(2011年) 主题范畴： PSYCHIATRY 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal The American Journal of Psychiatry is the most widely read psychiatric journal in the world. Published monthly, it is indispensable for all psychiatrists and other mental health professionals who need to keep up-to-date with all aspects of psychiatry. Peer-reviewed articles focus on developments in biological psychiatry as well as on treatment innovations and forensic, ethical, economic, and social topics. Letters to the editor and book reviews also appear in each issue; official American Psychiatric Association reports appear from time to time. Of special interest are the overview and other special lead articles, which treat major psychiatric syndromes and issues in depth. Instructions to Authors GENERAL POLICIES The requirements stated below are in accordance with the International Committee of Medical Journal Editors. See "Uniform Requirements for Manuscripts Submitted to Biomedical Journals," Ann Intern Med 1997; 126:36-47 (icmje.org). Prior Publication Manuscripts are accepted for consideration by The American Journal of Psychiatry with the understanding that they represent original material, have not been published previously, are not being considered for publication elsewhere, and have been approved by each author. Any form of publication other than an abstract of no more than 400 words constitutes prior publication. This includes components of symposia, proceedings, transactions, books (or chapters), invited articles, or reports of any kind, regardless of differences in readership, as well as electronic databases of a public nature. (Clinical trial registration does not constitute prior publication and will not preclude consideration for publication in the Journal.) Authors submitting manuscripts containing data or clinical observations already used in published papers or used in papers that are in press, submitted for publication, or to be submitted shortly should provide this information and copies of those papers to the Editor. An explanation of the differences between the papers should be included. You can send your Authorship, Disclosure, and Copyright Transfer in by mail or fax after you have been notified that your article has been accepted for publication. Clinical Trial Registration The American Journal of Psychiatry requires, as a condition of consideration for publication, registration of clinical trials in a public trials registry. Trials must be registered at or before the onset of patient enrollment. For this purpose, a clinical trial is defined as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (for example, phase I trials), would be exempt. The Journal does not advocate one particular registry, but requires authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a not-for-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include at minimum the following information: a unique identifying number, a statement of the intervention (or interventions) and comparison (or comparisons) studied, a statement of the study hypothesis, definitions of the primary and secondary outcome measures, eligibility criteria, key trial dates (registration date, anticipated or actual start date, anticipated or actual date of last follow-up, planned or actual date of closure to data entry, and date trial data considered complete), target number of subjects, funding source, and contact information for the principal investigator. To our knowledge, at present, only www.clinicaltrials.gov, sponsored by the United States National Library of Medicine, meets these requirements; there may be other registries, now or in the future, that meet all these requirements. Registration information must be provided in the cover letter at submission. Authorship All persons designated as authors should qualify for authorship. Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should be based on substantial contributions to 1) conception and design or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content, and on 3) final approval of the version to be published. Conditions 1, 2, and 3 must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is also not sufficient. Any part of an article critical to its main conclusions must be the responsibility of at least one author. Only those with key responsibility for the material in the article should be listed as authors; others contributing to the work should be recognized in an Acknowledgment (because readers may infer endorsement of the data and conclusions, all persons acknowledged must give written permission for their contribution to be noted in print. It is the corresponding author's responsibility to obtain written permission.) Editors will require authors to justify the assignment of authorship. A certification of authorship form, which must be signed by all authors, is available. (click here) Disclosure of Competing Interests All forms of support, including drug company support, must be acknowledged in the author's footnote (see "Acknowledgments" under the Title Page section). Also, authors must disclose in their cover letter any commercial or financial involvements that might present an appearance of a conflict of interest in connection with the submitted article, including but not limited to institutional or corporate affiliations not already specified in the author's footnote, paid consultancies, stock ownership or other equity interests, patent ownership, royalties from rating scales, inventions, therapy methods, and funds for travel. At the Editor's discretion, this information may be shared with reviewers. Such involvements will not be grounds for automatic rejection of the manuscript. Should the article be accepted for publication, the Editor and the authors will draft a statement that will be published with the article. A disclosure of competing interests form, which must be signed by all authors upon acceptance of the paper, is available. (click here) Copyright Transfer and Submission Approval The Journal requires approval of manuscript submission by all authors in addition to transfer of copyright to the American Psychiatric Association so that the author(s) and the Association are protected from misuse of copyrighted material. A copyright transfer form, which must be signed by all authors upon acceptance of the paper, is available. (click here) Accepted manuscripts will not be scheduled for publication until a completed form has been received in the editorial office. It is the author's responsibility to obtain the approval of individuals before acknowledging their assistance in the paper. In addition, authors must obtain letters of permission from publishers for use of extensive quotations (more than 500 words) or figures that have been previously published or submitted elsewhere. Patient Anonymity Ethical and legal considerations require careful attention to the protection of a patient's anonymity in case reports and elsewhere. Identifying information such as names, initials, hospital numbers, and dates must be avoided. Also, authors should disguise identifying information when discussing patients' characteristics and personal history. Informed Consent Manuscripts and letters to the Editor that report the results of experimental investigation and interviews with human subjects must include a statement that written informed consent was obtained after the procedure(s) had been fully explained. In the case of children, authors are asked to include information about whether the child's assent was obtained. If your submission does not contain written informed consent or Institutional Review Board approval, it will not be reviewed. Review Process All manuscripts receive an initial review by the Journal Editor and/or Deputy Editors to determine the originality, validity, and importance of content and conclusions. Manuscripts with insufficient priority for publication will be rejected promptly. Other manuscripts are sent for peer review. Authors will be sent reviewer comments that are judged to be useful to them. All reviewers remain anonymous. Authors are informed about the Editor's decision after the review process is completed. SUBMISSION OF MANUSCRIPTS The American Journal of Psychiatry has implemented a Web-based manuscript submission and tracking system to accelerate the peer review process and shorten the time from manuscript submission to publication decision. Thus, The American Journal of Psychiatry WILL NO LONGER BE ACCEPTING MANUSCRIPTS AND LETTERS BY MAIL. To submit your paper, please visit the manuscript submission site at Manuscript Central and either create an account or use your existing account. Then follow the instructions to upload your manuscript. All submissions must include a title page and be accompanied by a cover letter and list of suggested reviewers. TYPES OF ARTICLES Reviews Review articles are intended to bring together important information on a topic of general interest to psychiatry. This section is not intended to be a forum for the presentation of new data or meta-analyses. Review articles are usually solicited by the Editors, but we will consider unsolicited material. Please contact the editorial office before writing a Review Article for the Journal. The text cannot exceed 5,000 words with an abstract of no more than 250 words, a maximum of 5 tables and figures (total), and up to 50 references. Word count includes only the main body of text (i.e., not tables, figures, abstracts or references). Additional tables or figures can be submitted in a separate file as supplemental data for posting online. (See supplemental Data?for what types of data and formats are acceptable for posting online.) Articles Articles are reports of original work that embodies scientific excellence in psychiatric medicine and advances in clinical research. Typically, articles will contain new data derived from a sizable series of patients or subjects. The text cannot exceed 3,500 words which does not include an abstract of no more than 250 words, a maximum of 5 tables and figures (total), and up to 40 references. Word count includes only the main body of text (i.e., not tables, figures, abstracts or references). Additional tables can be submitted in a separate file as supplemental data for posting online. (See supplemental Data?for what types of data and formats are acceptable for posting online.) Brief Reports Brief reports present 1) a study that makes a single point, 2) worthwhile replication studies, and 3) negative studies of important topics. Essays, program descriptions, literature reviews, and case reports do not meet the criteria for this section. The text cannot exceed 1,500 words in addition to an abstract of no more than 150 words, no more than one table or one figure, and up to 15 references.Word count includes only the main body of text (i.e., not tables, figures, abstracts or references). Other Sections Letters to the Editor. Brief letters (maximum of 500 words, including references) will be considered if they include a cover letter indicating that the correspondence is "for publication." Novel case reports and other uncontrolled observations should be submitted as letters to the Editor. Case reports will be peer reviewed. Letters critical of an article published in the Journal must be received within 6 weeks of the article's publication. Letters received after the deadline will not be considered for publication; those considered will be sent to the authors for reply. Such letters must include the title and author of the article and the month and year of publication. Letters that do not meet these specifications will be returned unreviewed. Letters will be published on a space-available basis. Book Forum. Books for review should be sent to the Book Forum Editor, American Journal of Psychiatry, 1000 Wilson Blvd., Ste. 1825, Arlington, VA 22209. Book reviews are usually solicited by the Book Forum Editor. Authors interested in reviewing a particular book should send an e-mail to ajp@psych.org . Reprints of reviews are not available. Clinical Case Conferences. Clinical case conferences are disguised accounts of the diagnosis and treatment of actual patients who present interesting problems. The patient's history should be presented in some detail. A critical element is that the case should have been discussed in a departmental forum. Interesting cases seen only by individuals are more suitable for letters to the Editor. Clinical case conferences are usually solicited by the Editors, but we will consider unsolicited material. Please contact the editorial office before writing a clinical case conference for the Journal. The text of clinical case conferences cannot exceed 4,500 words with up to 20 references. Treatment in Psychiatry. The series highlights issues in treatment that are frequently encountered, but recognized to be difficult. An idealized case vignette in a brief paragraph summarizes the clinical issue. The authorship can be single or multiple, but needs to include a senior author who has well known expertise. The author discusses the pathophysiology and psychopathology and reviews the evidence in the literature for particular treatments. The discussion should not just reiterate guidelines, but rather present the results of studies that support an approach. The concluding paragraphs summarize what the author believes is best to do, given the available evidence and experience. Treatment in Psychiatry articles are usually solicited by the Editors, but we will consider unsolicited material. Please contact the editorial office before writing a Treatment in Psychiatry article for the Journal. The text should be limited to 2,400 words with up to 20 references and 1 figure. Introspections. Brief personal vignettes of experiences that have been particuarly important¡ªmoments of insight or inspiration¡ªwill be considered for publication. Introspections should be limited to 1,000 words. MANUSCRIPT ORGANIZATION AND FORMAT All parts of the manuscript or letter to the Editor, including case reports, quotations, references, and tables, must be double-spaced throughout. The manuscript should be arranged in the following order, with each item beginning a new page: 1) cover letter, 2) title page, 3) abstract, 4) text, 5) references, and 6) tables and/or figures. All pages must be numbered. STYLE SPECIFICATIONS Cover Letter Cover letters should include statements regarding Authorship, Disclosure, and Copyright Transfer. Also, it must include a list of 6 suggested reviewers and their e-mail addresses. Title Page Word count. The number of words in the manuscript (including abstract, text, and references) and the number of tables and figures should be noted in the upper right-hand corner of the title page. Tables and figures are no longer included in the word count. Title. The title should be informative, declarative, and as brief as possible. Byline. See instructions for Authorship. Authors' first names are preferred over initials. Degrees should be included after each author's name. Previous presentation. If the paper has been presented at a meeting, give the name of the meeting, the location, and the inclusive dates. Location of work and address for reprints. Provide the department, institution, city, and state where the work was done. Include a full address for the author who is to receive reprint requests. Acknowledgments. Grant support should be acknowledged in a separate paragraph and should include the full name of the granting agency and grant number. See instructions for Disclosure of Competing Interests. Acknowledgment of individuals should not exceed four typed lines. Drug company support of any kind must be acknowledged. Abstract The abstract is a single paragraph no longer than 250 words for Reviews and Overviews and Articles and no longer than 150 words for Brief Reports. All manuscripts should include structured abstracts with the following information, under the headings indicated: Objective-the primary purpose of the article; Method-data sources, subjects, design, measurements, data analysis; Results-key findings; and Conclusions-implications, future directions. If applicable, clinical trial registration information (name, number, and URL) should be listed at the end of the abstract. Text The contents of the text should include four major sections: introduction, method, results, and discussion. The method section should provide a comprehensive description of the nature of the study group, methods for recruitment, measurement and evaluation techniques (including information about reliability as appropriate), and data analysis. At the end of the section describing the subjects it should be clearly stated that "After complete description of the study to the subjects, written informed consent was obtained." Strengths and weaknesses of the study should be presented in the discussion. Patient Perspectives. As part of a new focus of presenting research in the Journal, authors are strongly encouraged to include as part of their submission a brief clinical vignette in which the experience of the trial is captured from the point of view of one or more subjects. These vignettes should not simply be a summary of a patient's demographic and clinical characteristics, as would be included in a case report, but rather an idea of the patient's subjective experience of participating in the study, obtained from notes or recollections of raters who perform structured clinical interviews, actual quotes from subjects, or some other mechanism. The vignettes, which should be no more than two paragraphs, will be set apart from the main body of the article in a shaded text box entitled patient Perspectives.? Data Analysis. Adequate description of statistical analysis should be provided, including the names of the statistical tests and whether tests were one- or two-tailed. Standard deviations, rather than standard errors of the mean, are required. Statistical tests that are not well-known should be referenced. All significant and important nonsignificant results must include the test value, degree(s) of freedom, and probability. For manuscripts that report on randomized clinical trials, authors should provide a flow diagram in CONSORT format and all of the information required by the CONSORT checklist. When word limits prevent the inclusion of some of this information in the manuscript, it should be provided in a separate document submitted with the manuscript for posting online. The CONSORT statement, checklist, and flow diagram can be found at http://www.consort-statement.org. (See supplemental Data?for what types of data and formats are acceptable for posting online.) Abbreviations. Spell out all abbreviations (other than those for units of measure) the first time they are used. Idiosyncratic abbreviations should not be used. Drugs. Generic rather than trade names of drugs should be used. References References are numbered and listed by their order of appearance in text; the text citation is followed by the appropriate reference number in parentheses. Do not arrange the list alphabetically. References in tables and figures are numbered as though the tables and figures were part of the text. References should be restricted to closely pertinent material. Accuracy of citation is the author's responsibility. References should conform exactly to the original spelling, accents, punctuation, etc. Authors should be sure that all references listed have been cited in text. Personal communications, unpublished manuscripts, manuscripts submitted but not yet accepted, and similar unpublished items should not appear in the reference list. Such citations may be noted in text. It is the author's responsibility to obtain permission to refer to another individual's unpublished observations. Manuscripts that are actually in press may be cited as such in the reference list; the name of the journal or publisher and location must be included. References to the editions of DSM should not be included in the reference list. Type references in the Vancouver style shown below, double-spaced throughout. List all authors; do not use "et al." Abbreviations of journal names should conform to the style used in Index Medicus; journals not indexed there should not be abbreviated. Zinbarg RE, Barlow DH, Liebowitz M, Street L, Broadhead E, Katon W, Roy-Byrne P, Lepine J-P, Teherani M, Richards J, Brantley PJ, Kraemer H: The DSM-IV field trial for mixed anxiety-depression. Am J Psychiatry 1994; 151:1153-1162 Beahrs JO: The cultural impact of psychiatry: the question of regressive effects, in American Psychiatry After World War II: 1944-1994. Edited by Menninger RW, Nemiah JC. Washington, DC, American Psychiatric Press, 2000, pp 321-342 Burrows GD, Norman TR, Judd FK, Marriott PF: Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders. J Psychiatr Res 1990; 24(suppl 2):65-72 Tables The Journal does not publish tables that have been submitted elsewhere or previously published. Tables that duplicate material contained elsewhere in the manuscript (in text, figures, or other tables) will not be used. Authors should delete tables containing data that could be given succinctly in text. A copy of each table must be submitted with the manuscript and must be accessible for copyediting. Tables cannot be embedded within the document or provided as figure art. Authors providing tables in such a manner will be required to resubmit tables in a format that allows for copyediting. In terms of data presentation, values expressed in the same unit of measurement should read down, not across; when percentages are presented, the appropriate numbers must also be given. For other guidelines, consult recent issues of the Journal. Figures As part of a new focus of presenting research in the Journal, all authors are encouraged to include as part of their submission a figure that summarizes the major findings of the study. The Journal encourages the submission of high-quality color figures (previously published figures should not be used). They should be made as visually appealing as possible. Multiple figures for the same article should be prepared as a set, consistent in color and size across all figures. The cost of publishing all illustrations, including color figures, is borne by the Journal. Consult recent issues of the Journal and the following guidelines for format. A copy of each figure should be submitted with the manuscript. If accepted, figures in manuscripts should be sent as high-resolution .eps or .tif files. Submission A copy of each figure must accompany the manuscript. Figure titles and footnotes should be provided on a separate page. If figures have been previously adapted from an earlier publication, the author must secure written permission from the holder of copyright for use in the Journal. The author should submit a copy of the permission release and credit lines if the manuscript is accepted for publication. Format Do not extend the vertical or horizontal axis of a graph beyond the point needed for the data shown. Definitions of symbols appearing in the figure should be presented in a key within the figure, rather than in the title or footnotes. Except for the key, avoid using internal type (e.g., placing statistical values within a graph). Two-dimensional graphs should not be represented in three dimensions. Content Each complete figure (including titles and footnotes) should be understandable without reference to the text. Figures should represent data visually rather than numerically. If error bars are included, standard deviations, rather than standard errors of the mean, should be used. Only the most widely recognized abbreviations may be used. In a graph comparing different groups of subjects, the number of subjects in each group should appear with the name of the group--in the key, in the headings below the horizontal axis, or in the title. Ordinary footnotes should be cited with lower-case superscript letters. Footnote citations may be given in both the title and the body of the figure; within the body of the figure, they should proceed from left to right. For statistical comparisons noted in figures, provide complete statistical data in footnotes (see example). If numerous analyses are presented, simple p values may be given in the footnotes, in which case the footnotes should be indicated by single asterisk, double asterisk, etc. Supplemental Data The Journal now allows authors to submit supplemental data to be posted online in support of their printed articles. To be accepted for posting, supplemental material must be essential to the scientific integrity and excellence of the manuscript. The material is subject to the same editorial standards as the printed Journal and will be submitted for peer review. The Editor may select material submitted for publication in the print version to be posted online only. The Journal will accept the following categories of supplemental data: ?Detailed tables (up to 3) that contain data of use to other investigators. Data should be summarized in the text of the print version ?The CONSORT table and figure for clinical trials are also appropriate for online publication only. ?Appendices. Questionnaires, tests, checklists, etc., should be submitted as supplemental data. Supplemental data should be uploaded in a separate file from the for-print manuscript. Please remember that the larger the file size the longer it will take users to download. For this reason, please limit your files to 10 MB. The Journal can accept the following formats: Description (Suffix) Plain Text (.txt) HTML Page (.html) JPEG Image (.jpg) GIF Image (.gif) Adobe PDF (.pdf) Excel Spreadsheet (.xls) ZIP Compressed File (.zip) Word Document (.doc) Tiff Image (.tif) PowerPoint (.ppt) Encapsulated Postscript (.eps) If your document type is not listed here, please contact the editorial office at ajp@psych.org. Please name your files and cite within the printed text as ST1 for tables, SF1 for figures, SR1 for references, and SA1 for appendices. PROCESSING OF ACCEPTED MANUSCRIPTS Manuscripts are accepted with the understanding that the Editor-in-Chief and the editorial staff have the right to make revisions aimed at greater conciseness, clarity, and conformity with Journal style. Accepted papers will be edited and sent to the corresponding author for corrections and answers to editorial queries. No proofs are sent to authors. Authors who will be away from their offices for a long period or who change address after notification of acceptance should inform the Journal staff. PERMISSION TO REPRINT Written permission to reprint material published in the Journal must be secured from the APA Publishing Services Division, 1000 Wilson Blvd., Suite 1825, Arlington, VA 22209-3901; telephone: 703-907-7866; fax: 703-907-1092; e-mail cthompson@psych.org . There is usually a charge for such permission, except for nonprofit classroom or library reserve use by instructors and educational institutions or for authors who wish to reprint their own material. REPRINTS No reprints are furnished gratis. An order form for reprints will be sent to the corresponding author before publication of the paper. The printer usually mails reprints approximately 6 weeks after the article has been published. Articles, Book Forum reviews, and Letters to the Editor may be downloaded by subscribers from the Journal Internet site ajp.psychiatryonline.org. Information on commercial reprint orders may be obtained by contacting the publisher: phone: 703-907-7894; fax: 703-907-1096; or e-mail: ajp@psych.org . To contact the AJP editorial office, call or write: The American Journal of Psychiatry 1000 Wilson Blvd., Suite 1825 Arlington, VA 22209 Phone: 703-907-8680 or 703-907-7885 Fax: 703-907-1096 E-mail: ajp@psych.org File modified 04/06/2005 Editorial Board Editor-in-Chief Robert Freedman, M.D. Deputy Editors David A. Lewis, M.D. Robert Michels, M.D. Daniel S. Pine, M.D. Susan K. Schultz, M.D. Carol A. Tamminga, M.D. Associate Editors Francine M. Benes, M.D., Ph.D. Wade H. Berrettini, M.D., Ph.D. Kathleen T. Brady, M.D. David A. Brent, M.D. Cameron S. Carter, M.D. J. Raymond DePaulo, Jr., M.D. Leon Eisenberg, M.D. Glen O. Gabbard, M.D. Howard H. Goldman, M.D., Ph.D. Jeffrey A. Lieberman, M.D. Robert C. Malenka, M.D., Ph.D. Maria A. Oquendo, M.D. Barbara L. Parry, M.D. Larry J. Siever, M.D. Myrna M. Weissman, Ph.D. Editor Emeritus Nancy C. Andreasen, M.D., Ph.D. John C. Nemiah, M.D. EDITORIAL STAFF Editorial Director Sandra L. Patterson Editorial Manager Michael D. Roy Senior Editor/Features Writer Jane Weaver, E.L.S. Senior Editors John J. Guardiano, Ph.D. Leannah M. Harding, M.S., E.L.S. Assistant Editor Angela Moore Production Editor Julie C. Blair Graphic Designer Jason Glance Peer Review Administrator Molly Douglas Editorial Assistants Lisa Devine Astewaye Yigzaw Assistants to the Editors Lois Campbell Aniko Evans Rachel Hogg Russell A. Scholl